Henry Ford Medical Center

Detroit, Michigan 49202

3 studies enrolling now · 46 studies all time

What they study most

Acne, Acne Vulgaris, Acute Kidney Injury, Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Acute Respiratory Distress Syndrome, Acute Respiratory Infection, Advanced or Metastatic Solid Tumors, Advanced/Metastatic Solid Malignancies, Anterior Wall Acute Myocardial Infarction, Asthma

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis — Recruiting now
• Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury — Recruiting now
• Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hyperpigmentation — Recruiting now
• Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia — Running, not enrolling
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
• Optimizing Phototesting and Investigating Photobiology of Visible Light — Running, not enrolling
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS — Completed
• Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) — Completed
• Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo — Completed
• Topical Ruxolitinib Evaluation in Chronic Hand Eczema — Completed
• Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC — Running, not enrolling
• M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) — Completed
• Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL — Stopped early
• Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery — Completed
• Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy — Completed
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT) — Completed
• Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis — Completed
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) — Completed
• Prospective Global Registry for the Study of Chronic Total Occlusion Intervention — Status unconfirmed
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) — Completed
• FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Completed
• IBI308 in Subjects With Advanced/Metastatic Solid Malignancies — Completed
• Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) — Completed
• Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease — Completed
• Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Vitamin D to Improve Outcomes by Leveraging Early Treatment — Completed
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis — Stopped early
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed
• Phase III Confirmatory Study in Erythropoietic Protoporphyria — Completed
• A Multi-Center Trial of the ProLung Test™ — Completed
• Reevaluation Of Systemic Early Neuromuscular Blockade — Completed
• Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis — Completed
• Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis — Completed
• Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU) — Completed
• Asthma Intervention Research 2 (AIR2) Trial — Completed
• A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel — Completed
• A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne — Completed
• E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer — Stopped early
• Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional — Completed
• The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis — Completed
• Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) — Completed
• A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea — Completed
• Non-small Cell Lung Cancer Registry — Completed
• A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris — Completed